287 related articles for article (PubMed ID: 18590843)
1. Pseudomyxoma peritonei.
Smeenk RM; Bruin SC; van Velthuysen ML; Verwaal VJ
Curr Probl Surg; 2008 Aug; 45(8):527-75. PubMed ID: 18590843
[No Abstract] [Full Text] [Related]
2. One of the most difficult management problems in surgery is pseudomyxoma peritonei. Foreword.
Wells SA
Curr Probl Surg; 2008 Aug; 45(8):521. PubMed ID: 18590841
[No Abstract] [Full Text] [Related]
3. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases.
Jacquemin G; Laloux P
Acta Chir Belg; 2005 Apr; 105(2):127-33. PubMed ID: 15906901
[TBL] [Abstract][Full Text] [Related]
4. [Pseudomyxoma peritonei].
Iversen LH; Rasmussen PC; Wara P; Ambrose NS; Laurberg S
Ugeskr Laeger; 2004 Aug; 166(35):2979-81. PubMed ID: 15387006
[No Abstract] [Full Text] [Related]
5. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
Smeenk RM; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?
Elias D; Duchalais E; David A; Dartigues P; Duvillard P; Poirot C; Goéré D
Eur J Surg Oncol; 2013 Jul; 39(7):748-53. PubMed ID: 23523317
[TBL] [Abstract][Full Text] [Related]
7. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H
Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859
[TBL] [Abstract][Full Text] [Related]
8. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate.
Chua TC; Liauw W; Zhao J; Morris DL
Ann Surg; 2011 Apr; 253(4):769-73. PubMed ID: 21475018
[TBL] [Abstract][Full Text] [Related]
9. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
[TBL] [Abstract][Full Text] [Related]
10. Pseudomyxoma peritonei syndrome.
Sugarbaker PH; Ronnett BM; Archer A; Averbach AM; Bland R; Chang D; Dalton RR; Ettinghausen SE; Jacquet P; Jelinek J; Koslowe P; Kurman RJ; Shmookler B; Stephens AD; Steves MA; Stuart OA; White S; Zahn CM; Zoetmulder FA
Adv Surg; 1996; 30():233-80. PubMed ID: 8960339
[No Abstract] [Full Text] [Related]
11. [Treatment possibilities in malignant pleural and peritoneal effusions and pseudomyxoma peritonei].
Meerpohl HG; Karck U
Gynakologe; 1992 Apr; 25(2):89-98. PubMed ID: 1377158
[No Abstract] [Full Text] [Related]
12. Treatment of pseudomyxoma peritonei with two times--cytoreduction and hypertermic antiblastic peritoneal perfusion (HAPP).
De Simone M; Scuderi S; Vaira M; Costamagna D; Barone R; Fiorentini G; Dentico P; Caponi A; Ciaccio B; Caponi C; Ferri L; Martini E; Cantini S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):25-8. PubMed ID: 16767902
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival.
Huang HC; Huang YS; Shyr YM; Yen SH; Chang FY; Lee SD
Hepatogastroenterology; 2002; 49(46):999-1001. PubMed ID: 12143263
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal pseudomyxoma].
de Bree E; Tsiftsis DD
Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2469. PubMed ID: 9555133
[No Abstract] [Full Text] [Related]
15. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
[TBL] [Abstract][Full Text] [Related]
16. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases.
Carr NJ; Finch J; Ilesley IC; Chandrakumaran K; Mohamed F; Mirnezami A; Cecil T; Moran B
J Clin Pathol; 2012 Oct; 65(10):919-23. PubMed ID: 22718846
[TBL] [Abstract][Full Text] [Related]
17. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion.
De Simone M; Vaira M; Caponi A; Ciaccio B; Fiorentini G; Turrisi G; Ferri L; Buti G
In Vivo; 2006; 20(6A):725-7. PubMed ID: 17203755
[TBL] [Abstract][Full Text] [Related]
18. The etiology, clinical presentation, and management of pseudomyxoma peritonei.
Moran BJ; Cecil TD
Surg Oncol Clin N Am; 2003 Jul; 12(3):585-603. PubMed ID: 14567019
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Dang A; Mansfield P; Ilsin B; Hightower C; Aravindan N; Rice D; Riedel B
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):265-8. PubMed ID: 17418746
[No Abstract] [Full Text] [Related]
20. The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome.
Spiliotis J; Efstathiou E; Halkia E; Vaxevanidou A; Datsis A; Sugarbaker P
Hepatogastroenterology; 2012 May; 59(115):705-8. PubMed ID: 22469712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
